-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $65

Benzinga·10/19/2026 13:11:49
Listen to the news
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:EXEL) with a Market Outperform and raises the price target from $55 to $65.